Advertisement
Screener

PRESTIGE CONSUMER HEALTHCARE INC. (PBH) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

PRESTIGE CONSUMER HEALTHCARE INC. Operating Cash Flow

PRESTIGE CONSUMER HEALTHCARE INC. (PBH) reported Operating Cash Flow of $70.79 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06

  • PRESTIGE CONSUMER HEALTHCARE INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $70.79M, a 10.41% decline year-over-year.
  • PRESTIGE CONSUMER HEALTHCARE INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $42.84M, a 30.73% decline year-over-year.
  • PRESTIGE CONSUMER HEALTHCARE INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $78.29M, a 20.27% increase year-over-year.
  • PRESTIGE CONSUMER HEALTHCARE INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $57.49M, a 17.64% decline year-over-year.
  • PRESTIGE CONSUMER HEALTHCARE INC. net cash provided by (used in) operating activities for fiscal 2026 was $257.63M, a 2.43% increase from fiscal 2025.
  • PRESTIGE CONSUMER HEALTHCARE INC. net cash provided by (used in) operating activities for fiscal 2025 was $251.51M, a 1.04% increase from fiscal 2024.
  • PRESTIGE CONSUMER HEALTHCARE INC. net cash provided by (used in) operating activities for fiscal 2024 was $248.93M, a 8.36% increase from fiscal 2023.
  • PRESTIGE CONSUMER HEALTHCARE INC. net cash provided by (used in) operating activities for fiscal 2023 was $229.72M, a 11.62% decline from fiscal 2022.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 3 month as first filedNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 6 month as first filedNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 9 month as first filedNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 12 month as first filed
2026-06-30$70.79M
10-Q · filed 2026-08-06
$113.63M
derived: sum of 2 quarters · filed 2026-08-06
$191.92M
derived: sum of 3 quarters · filed 2026-08-06
$249.40M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$42.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-14
$121.13M
derived: sum of 2 quarters · filed 2026-05-14
$178.61M
derived: sum of 3 quarters · filed 2026-05-14
$257.63M
10-K · filed 2026-05-14
2025-12-31$78.29M
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-05
$135.77M
derived: sum of 2 quarters · filed 2026-02-05
$214.79M
10-Q · filed 2026-02-05
$276.63M
derived: sum of 4 quarters · filed 2026-08-06
2025-09-30$57.49M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06
$136.50M
10-Q · filed 2025-11-06
$198.35M
derived: sum of 3 quarters · filed 2026-08-06
$263.44M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$79.01M
10-Q · filed 2026-08-06
$140.86M
derived: sum of 2 quarters · filed 2026-08-06
$205.95M
derived: sum of 3 quarters · filed 2026-08-06
$275.75M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$61.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-14
$126.94M
derived: sum of 2 quarters · filed 2026-05-14
$196.74M
derived: sum of 3 quarters · filed 2026-05-14
$251.51M
10-K · filed 2026-05-14
2024-12-31$65.09M
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-05
$134.89M
derived: sum of 2 quarters · filed 2026-02-05
$189.67M
10-Q · filed 2026-02-05
$256.57M
derived: sum of 4 quarters · filed 2026-05-14
2024-09-30$69.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06
$124.58M
10-Q · filed 2025-11-06
$191.48M
derived: sum of 3 quarters · filed 2026-05-14
$262.95M
derived: sum of 4 quarters · filed 2026-05-14
2024-06-30$54.78M
10-Q · filed 2025-08-07
$121.68M
derived: sum of 2 quarters · filed 2026-05-14
$193.16M
derived: sum of 3 quarters · filed 2026-05-14
$255.62M
derived: sum of 4 quarters · filed 2026-05-14
2024-03-31$66.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-14
$138.38M
derived: sum of 2 quarters · filed 2026-05-14
$200.84M
derived: sum of 3 quarters · filed 2026-05-14
$248.93M
10-K · filed 2026-05-14
2023-12-31$71.47M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-06
$133.93M
derived: sum of 2 quarters · filed 2025-02-06
$182.02M
10-Q · filed 2025-02-06
$241.01M
derived: sum of 4 quarters · filed 2025-05-09
2023-09-30$62.46M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07
$110.55M
10-Q · filed 2024-11-07
$169.53M
derived: sum of 3 quarters · filed 2025-05-09
$224.48M
derived: sum of 4 quarters · filed 2025-05-09
2023-06-30$48.09M
10-Q · filed 2024-08-08
$107.07M
derived: sum of 2 quarters · filed 2025-05-09
$162.02M
derived: sum of 3 quarters · filed 2025-05-09
$219.56M
derived: sum of 4 quarters · filed 2025-05-09
2023-03-31$58.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-09
$113.93M
derived: sum of 2 quarters · filed 2025-05-09
$171.47M
derived: sum of 3 quarters · filed 2025-05-09
$229.72M
10-K · filed 2025-05-09
2022-12-31$54.94M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08
$112.48M
derived: sum of 2 quarters · filed 2024-02-08
$170.73M
10-Q · filed 2024-02-08
$233.85M
derived: sum of 4 quarters · filed 2024-05-15
2022-09-30$57.54M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-02
$115.79M
10-Q · filed 2023-11-02
$178.91M
derived: sum of 3 quarters · filed 2024-05-15
$245.21M
derived: sum of 4 quarters · filed 2024-05-15
2022-06-30$58.25M
10-Q · filed 2023-08-03
$121.37M
derived: sum of 2 quarters · filed 2024-05-15
$187.67M
derived: sum of 3 quarters · filed 2024-05-15
$248.86M
derived: sum of 4 quarters · filed 2024-05-15
2022-03-31$63.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-15
$129.42M
derived: sum of 2 quarters · filed 2024-05-15
$190.62M
derived: sum of 3 quarters · filed 2024-05-15
$259.92M
10-K · filed 2024-05-15
2021-12-31$66.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-02
$127.49M
derived: sum of 2 quarters · filed 2023-02-02
$196.80M
10-Q · filed 2023-02-02
$255.88M
derived: sum of 4 quarters · filed 2023-05-05
2021-09-30$61.19M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-03
$130.50M
10-Q · filed 2022-11-03
$189.59M
derived: sum of 3 quarters · filed 2023-05-05
$238.81M
derived: sum of 4 quarters · filed 2023-05-05
2021-06-30$69.31M
10-Q · filed 2022-08-04
$128.39M
derived: sum of 2 quarters · filed 2023-05-05
$177.62M
derived: sum of 3 quarters · filed 2023-05-05
$229.76M
derived: sum of 4 quarters · filed 2023-05-05
2021-03-31$59.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-05
$108.31M
derived: sum of 2 quarters · filed 2023-05-05
$160.45M
derived: sum of 3 quarters · filed 2023-05-05
$235.61M
10-K · filed 2023-05-05
2020-12-31$49.23M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-03
$101.37M
derived: sum of 2 quarters · filed 2022-02-03
$176.52M
10-Q · filed 2022-02-03
$232.65M
derived: sum of 4 quarters · filed 2022-05-06
2020-09-30$52.14M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-04
$127.29M
10-Q · filed 2021-11-04
$183.42M
derived: sum of 3 quarters · filed 2022-05-06
$241.42M
derived: sum of 4 quarters · filed 2022-05-06
2020-06-30$75.15M
10-Q · filed 2021-08-05
$131.28M
derived: sum of 2 quarters · filed 2022-05-06
$189.28M
derived: sum of 3 quarters · filed 2022-05-06
$239.50M
derived: sum of 4 quarters · filed 2022-05-06
2020-03-31$56.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-06
$114.12M
derived: sum of 2 quarters · filed 2022-05-06
$164.35M
derived: sum of 3 quarters · filed 2022-05-06
$217.12M
10-K · filed 2022-05-06
2019-12-31$58.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-04
$108.22M
derived: sum of 2 quarters · filed 2021-02-04
$161.00M
10-Q · filed 2021-02-04
$211.84M
derived: sum of 4 quarters · filed 2021-05-07
2019-09-30$50.22M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-05
$103.00M
10-Q · filed 2020-11-05
$153.85M
derived: sum of 3 quarters · filed 2021-05-07
$197.18M
derived: sum of 4 quarters · filed 2021-05-07
2019-06-30$52.78M
10-Q · filed 2020-08-06
$103.62M
derived: sum of 2 quarters · filed 2021-05-07
$146.95M
derived: sum of 3 quarters · filed 2021-05-07
$186.21M
derived: sum of 4 quarters · filed 2021-05-07
2019-03-31$50.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-07
$94.18M
derived: sum of 2 quarters · filed 2021-05-07
$133.43M
derived: sum of 3 quarters · filed 2021-05-07
$189.28M
10-K · filed 2021-05-07
2018-12-31$43.33M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-06
$82.58M
derived: sum of 2 quarters · filed 2020-02-06
$138.44M
10-Q · filed 2020-02-06
$192.88M
derived: sum of 4 quarters · filed 2020-05-08
2018-09-30$39.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-10-31
$95.11M
10-Q · filed 2019-10-31
$149.54M
derived: sum of 3 quarters · filed 2020-05-08
$196.68M
derived: sum of 4 quarters · filed 2020-05-08
2018-06-30$55.85M
10-Q · filed 2019-08-01
$110.29M
derived: sum of 2 quarters · filed 2020-05-08
$157.42M
derived: sum of 3 quarters · filed 2020-05-08
$211.84M
derived: sum of 4 quarters · filed 2020-05-08
2018-03-31$54.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-08
$101.57M
derived: sum of 2 quarters · filed 2020-05-08
$155.99M
derived: sum of 3 quarters · filed 2020-05-08
$210.11M
10-K · filed 2020-05-08
2017-12-31$47.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-07
$101.55M
derived: sum of 2 quarters · filed 2019-02-07
$155.67M
10-Q · filed 2019-02-07
$163.20M
derived: sum of 4 quarters · filed 2019-05-13
2017-09-30$54.42M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-01
$108.54M
10-Q · filed 2018-11-01
$116.06M
derived: sum of 3 quarters · filed 2019-05-13
$156.13M
derived: sum of 4 quarters · filed 2019-05-13
2017-06-30$54.12M
10-Q · filed 2018-08-02
$61.65M
derived: sum of 2 quarters · filed 2019-05-13
$101.71M
derived: sum of 3 quarters · filed 2019-05-13
$151.49M
derived: sum of 4 quarters · filed 2019-05-13
2017-03-31$7.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-05-13
$47.59M
derived: sum of 2 quarters · filed 2019-05-13
$97.37M
derived: sum of 3 quarters · filed 2019-05-13
$148.67M
10-K · filed 2019-05-13
$147.77M
10-K · filed 2017-05-17
2016-12-31$40.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-01
$89.85M
derived: sum of 2 quarters · filed 2018-02-01
$141.15M
10-Q · filed 2018-02-01
$140.35M
10-Q · filed 2017-02-02
$181.01M
derived: sum of 4 quarters · filed 2018-05-10
2016-09-30$49.78M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-02
$101.08M
10-Q · filed 2017-11-02
$100.28M
10-Q · filed 2016-11-03
$140.94M
derived: sum of 3 quarters · filed 2018-05-10
$186.80M
derived: sum of 4 quarters · filed 2018-05-10
2016-06-30$51.30M
10-Q · filed 2017-08-03
$50.75M
10-Q · filed 2016-08-04
$91.16M
derived: sum of 2 quarters · filed 2018-05-10
$137.02M
derived: sum of 3 quarters · filed 2018-05-10
$184.09M
derived: sum of 4 quarters · filed 2018-05-10
2016-03-31$39.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-10
$85.72M
derived: sum of 2 quarters · filed 2018-05-10
$132.79M
derived: sum of 3 quarters · filed 2018-05-10
$176.31M
10-K · filed 2018-05-10
$174.35M
10-K · filed 2016-05-17
2015-12-31$45.86M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-02
$92.93M
derived: sum of 2 quarters · filed 2017-02-02
$136.45M
10-Q · filed 2017-02-02
$188.56M
derived: sum of 4 quarters · filed 2017-05-17
2015-09-30$47.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-03
$90.59M
10-Q · filed 2016-11-03
$142.70M
derived: sum of 3 quarters · filed 2017-05-17
$189.79M
derived: sum of 4 quarters · filed 2017-05-17
2015-06-30$43.52M
10-Q · filed 2016-08-04
$95.63M
derived: sum of 2 quarters · filed 2017-05-17
$142.72M
derived: sum of 3 quarters · filed 2017-05-17
$170.10M
derived: sum of 4 quarters · filed 2017-05-17
2015-03-31$52.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-17
$99.20M
derived: sum of 2 quarters · filed 2017-05-17
$126.58M
derived: sum of 3 quarters · filed 2017-05-17
$156.25M
10-K · filed 2017-05-17
2014-12-31$47.08M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-04
$74.47M
derived: sum of 2 quarters · filed 2016-02-04
$104.14M
10-Q · filed 2016-02-04
$134.86M
derived: sum of 4 quarters · filed 2016-05-17
2014-09-30$27.39M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-05
$57.06M
10-Q · filed 2015-11-05
$87.78M
derived: sum of 3 quarters · filed 2016-05-17
$113.04M
derived: sum of 4 quarters · filed 2016-05-17
2014-06-30$29.67M
10-Q · filed 2015-08-06
$60.39M
derived: sum of 2 quarters · filed 2016-05-17
$85.66M
derived: sum of 3 quarters · filed 2016-05-17
$118.45M
derived: sum of 4 quarters · filed 2016-05-17
2014-03-31$30.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-05-17
$55.98M
derived: sum of 2 quarters · filed 2016-05-17
$88.78M
derived: sum of 3 quarters · filed 2016-05-17
$111.58M
10-K · filed 2016-05-17
2013-12-31$25.26M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-05
$58.06M
derived: sum of 2 quarters · filed 2015-02-05
$80.86M
10-Q · filed 2015-02-05
$117.59M
derived: sum of 4 quarters · filed 2015-05-14
2013-09-30$32.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-06
$55.60M
10-Q · filed 2014-11-06
$92.33M
derived: sum of 3 quarters · filed 2015-05-14
$132.83M
derived: sum of 4 quarters · filed 2015-05-14
2013-06-30$22.80M
10-Q · filed 2014-08-07
$59.53M
derived: sum of 2 quarters · filed 2015-05-14
$100.03M
derived: sum of 3 quarters · filed 2015-05-14
$145.66M
derived: sum of 4 quarters · filed 2015-05-14
2013-03-31$36.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-14
$77.23M
derived: sum of 2 quarters · filed 2015-05-14
$122.86M
derived: sum of 3 quarters · filed 2015-05-14
$137.60M
10-K · filed 2015-05-14
2012-12-31$40.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-07
$86.13M
derived: sum of 2 quarters · filed 2014-02-07
$100.88M
10-Q · filed 2014-02-07
$120.33M
derived: sum of 4 quarters · filed 2014-05-19
2012-09-30$45.63M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-07
$60.37M
10-Q · filed 2013-11-07
$79.83M
derived: sum of 3 quarters · filed 2014-05-19
$94.36M
derived: sum of 4 quarters · filed 2014-05-19
2012-06-30$14.74M
10-Q · filed 2013-08-01
$34.20M
derived: sum of 2 quarters · filed 2014-05-19
$48.73M
derived: sum of 3 quarters · filed 2014-05-19
$66.75M
derived: sum of 4 quarters · filed 2014-05-19
2012-03-31$19.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-05-19
$33.99M
derived: sum of 2 quarters · filed 2014-05-19
$52.01M
derived: sum of 3 quarters · filed 2014-05-19
$67.45M
10-K · filed 2014-05-19
2011-12-31$14.53M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-07
$32.55M
derived: sum of 2 quarters · filed 2013-02-07
$47.99M
10-Q · filed 2013-02-07
$73.00M
derived: sum of 4 quarters · filed 2013-05-17
2011-09-30$18.02M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-07
$33.47M
10-Q · filed 2012-11-07
$58.48M
derived: sum of 3 quarters · filed 2013-05-17
$77.32M
derived: sum of 4 quarters · filed 2013-05-17
2011-06-30$15.44M
10-Q · filed 2012-08-09
$40.45M
derived: sum of 2 quarters · filed 2013-05-17
$59.30M
derived: sum of 3 quarters · filed 2013-05-17
$81.40M
derived: sum of 4 quarters · filed 2013-05-17
2011-03-31$25.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-17
$43.85M
derived: sum of 2 quarters · filed 2013-05-17
$65.96M
derived: sum of 3 quarters · filed 2013-05-17
$86.67M
10-K · filed 2013-05-17
2010-12-31$18.84M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-09
$40.95M
derived: sum of 2 quarters · filed 2012-02-09
$61.66M
10-Q · filed 2012-02-09
2010-09-30$22.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-09
$42.82M
10-Q · filed 2011-11-09
2010-06-30$20.71M
10-Q · filed 2011-08-05
2010-03-31$59.43M
10-K · filed 2012-05-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Aurinia Pharmaceuticals Inc. (AUPH)$2.207B7.18
Bausch Health Companies Inc. (BHC)$2.113B-1.68
Braveheart Bio, Inc. (BRVE)United States$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
Zai Lab Ltd (ZLAB)$2.241B-113.34
Generate Biomedicines, Inc. (GENB)United States$2.052B
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05